Heavy Duty Trucking Flags Marijuana Testing Conflict for CDL Drivers

Federal Rules Still Override State Legalization

The U.S. Department of Transportation's testing rules in 49 CFR Part 40 make no exception for state-legal marijuana use. Heavy Duty Trucking framed the issue as a drug-testing dilemma for the industry on Oct. 5. The full text of that report wasn't available for this story. What follows rests on the federal regulations themselves.

For carriers, the stakes are operational. A single positive can sideline a driver just when companies are competing for qualified CDL holders.

What Part 40 Requires

Marijuana is one of five drug classes in the DOT panel, and a medical recommendation doesn't change a positive result. The key provisions:

• 49 CFR 40.85 lists marijuana metabolites alongside cocaine, amphetamines, opioids and PCP.
• 49 CFR 40.87 sets the THC-COOH cutoffs at 50 ng/mL for the initial test and 15 ng/mL for confirmation.
• 49 CFR 40.151(e) bars a medical review officer from verifying a test as negative because a physician recommended a Schedule I drug.

That last provision is the one that catches medical cannabis patients in California, Colorado and other legal states.

Clearinghouse Turns One Test Into a Record

A verified positive is reported to the FMCSA Drug and Alcohol Clearinghouse, where future employers can see it. Under 49 CFR Part 382, a driver with a violation can't perform safety-sensitive functions until completing the return-to-duty process with a substance abuse professional.

Employers must also query the database before hiring and annually. Not a minor compliance chore.

Hemp and CBD Create a Gray Zone

DOT has warned that CBD products aren't guaranteed to be THC-free, and it treats that as the driver's risk. A February 2020 DOT notice said mislabeled products can produce a positive result, and the agency added that CBD use isn't a legitimate medical explanation for one.

The 2018 Farm Bill's 0.3% delta-9 THC threshold for hemp doesn't map onto a 50 ng/mL urine cutoff. Drivers using hemp-derived products carry that exposure alone.

Testing Methods Are Shifting

DOT added oral fluid as an authorized specimen type in a 2023 final rule, giving employers a tool aimed at recent use. Urine testing, by contrast, can detect metabolites well after impairment has passed. That gap is the core policy complaint from drivers in legal states.

Carriers should audit their written policies against Part 40 and Part 382 now. The rules haven't moved, even where state law has.

What to Watch

Any change to marijuana's federal status would need a separate DOT rulemaking before testing obligations shift. A DEA rescheduling decision alone wouldn't rewrite Part 40, which is a distinct regulatory text. For full background, see the CannIntel topic hub on trucking drug testing and marijuana.

Watch for a DOT notice of proposed rulemaking amending Part 40, or HHS action on testing guidelines. Until one is docketed, the compliance baseline stays put.